Search |

Add/Edit My Facility

Augusta University (GRU)

Georgia Regents University

Established: 1828

https://www.augusta.edu

Location: Augusta, United States

GeoNames Map

Alternate Identifiers

ROR ID: https://ror.org/012mef835

CrossRef Funder ID: 100008578

ISNI: 0000 0001 2284 9329

WikiData: Q5547686

3 Core Facilities:

0 Service Outside the Institution

0 Consult Outside the Institution

Augusta University Georgia Cancer Center Immune Monitoring Shared Resource Core FacilityRRID:SCR_026590

Resources:
RRID:

RRID:SCR_026590

Description:

Core provides services in Assay Development, Assays Experimental Design, Immune Monitoring, Cytokine Assays, ELISA, multiplex Flow based and Luminex based Bead Arrays, Project Based Flow Cytometry and Data Analysis.

This facility does not provide services outside its institution

This facility does not consult outside its institution

Last updated:

03/21/2025

Augusta University Integrated Genomics Shared Resource Core FacilityRRID:SCR_026483

Resources:
RRID:

RRID:SCR_026483

Description:

Core offers services from sample processing from both fresh and frozen, as well as fixed cells or tissues to library preparation and next-generation sequencing (NGS) for bulk DNA/RNA sequencing and single-cell/nuclei sequencing. For single-cell studies, core is equipped with Chromium X system from 10X Genomics. Sequencing capabilities include Illumina Novaseq6000 and NextSeq 500. Offers single cell spatial transcriptomics with CosMx SMI platform. Other equipped includes CytAssit instrument from 10X genomics for VISIUM spatial transcriptomic and QIAConnect from Qiagen for nucleic acid and protein extraction.

This facility does not provide services outside its institution

This facility does not consult outside its institution

Last updated:

03/10/2025

Augusta University Therapeutics Core FacilityRRID:SCR_026475

Resources:
RRID:

RRID:SCR_026475

Description:

Core offers services including assay development, FDA-drug library screening, unbiased compound screening, high-content imaging and screening. Facility can empower researchers to repurpose existing FDA-approved drugs and discover new compounds for drug development. Provides affordable platform for discovering therapeutic targets and interventions, supporting drug development from target identification to screening and validation. Features HTS facilities, including Biomek i7 Liquid Handling system, Pherastar FSX plate reader, ImageXpress Micro Confocal, and Pala cell sorter.

This facility does not provide services outside its institution

This facility does not consult outside its institution

Last updated:

02/28/2025